The effects of sequential combined oral 17β-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: A randomized single blind placebo-controlled study

Menopause

Volumn 8, Issue 1, 2001, Pages 27-32

  Walker, R J ^a   Lewis Barned, N J ^a   Sutherland, W H F ^a   Goulding, A ^a   Edwards, E A ^a   De Jong, S A ^a   Gold, E ^a   Walker, H L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Body composition; Hormone replacement therapy; Insulin sensitivity; Randomized clinical trial

Indexed keywords

ESTRADIOL; FOLLITROPIN; NORETHISTERONE ACETATE; PLACEBO;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0035152190     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200101000-00006     Document Type: Article

References (35)

1. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
2. A prospective study of postmenopausal estrogen therapy and coronary heart disease
3. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: Evidence from a national cohort
4. Hormone replacement therapy and cardiovascular disease: The human model
5. The epidemiology of cardiovascular disease in postmenopausal women
6. Relative effects of pregnancy, estradiol and progesterone on plasma insulin and pancreatic islet insulin secretion
7. Ischemic heart disease risk in postmenopausal women: Effects of estrogen use on glucose and insulin levels
8. Effects of estrogen on glucose tolerance
9. The effect of estrogens on carbohydrate metabolism: Glucose, insulin, and growth hormone studies on one hundred and seventy-one women ingesting Premarin, mestranol, and ethinyl estradiol for six months
10. Carbohydrate metabolism during hormonal substitution therapy
11. Effects of low doses of transdermal 17β estradiol on carbohydrate metabolism in postmenopausal women
12. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women: The Menopause Study Group
13. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The postmenopausal estrogen/progestin interventions (PEPI) trial
14. Sex- and menopause-associated changes in body-fat distribution
15. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women
16. The influence of menopause and hormonal replacement therapy on body cell mass an d body fat mass
17. Age and menopause associated variation in body composition and fat distribution in healthy women as measured by dual energy x-ray absorptiometry
18. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women
19. Glucose clamp technique: A method for quantifying insulin secretion and resistance
20. A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping
21. Mechanisms of insulin resistance following trauma
22. Use of heated superficial hand vein as an alternate site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics
23. The effects of increasing doses of enalapril on insulin sensitivity in normotensive non-insulin dependent diabetic subjects
24. A model of the kinetics of insulin in man
25. DEXA supports the use of BMI as a measure of fatness in young girls
26. Plasma cholesterol esterification and transfer the menopause and hormone replacement therapy in women
27. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of adding progestin
28. Insulin resistance secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy
29. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women
30. Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in postmenopausal women
31. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal non-diabetic women
32. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden
33. Increased risk of atherosclerosis in women after menopause
34. Body weight, body fat distribution and hormonal replacement therapy in early postmenopausal women
35. Effect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women